Noboru Komiyama

Dr. Noboru Komiyama


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2020 in Science
Verified
Journal Article
Closed access
PDF file
MCMélissa Cizeron
Mélissa Cizeron
ZQZhen Qiu
Zhen Qiu
BKBabis Koniaris
Babis Koniaris
RGRagini Gokhale
Ragini Gokhale
NKNoboru Komiyama
Noboru Komiyama
SGSeth G.N. Grant
Seth G.N. Grant
Brain synapses through the life span: Excitatory synapses connect neurons in the brain to build the circuits that enable behavior. Cizeron et al. surveyed synapses in the mouse brain from birth to old age and present the data as a community resource, the Mouse Lifespan Synaptome Atlas (see the Perspective by Micheva et al. ). Molecular and morphological features defined 37 subtypes of synapses. Although synapse density generally increased in early development and declined in old age, the details differed in different brain areas. Science this issue p. 270 ; see also p. 253

2 December 2012 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
TRTomás J Ryan
Tomás J Ryan
MKMaksym V Kopanitsa
Maksym V Kopanitsa
TITim Indersmitten
Tim Indersmitten
JNJess Nithianantharajah
Jess Nithianantharajah
NANurudeen O Afinowi
Nurudeen O Afinowi
NKNoboru Komiyama
Noboru Komiyama
The authors examined the differential roles of GluN2A and GluN2B in modulating synaptic plasticity and behavior. This study provides insight into how gene duplication events during evolution can produce new functional consequences. Two genome duplications early in the vertebrate lineage expanded gene families, including GluN2 subunits of the NMDA receptor. Diversification between the four mammalian GluN2 proteins occurred primarily at their intracellular C-terminal domains (CTDs). To identify shared ancestral functions and diversified subunit-specific functions, we exchanged the exons encoding the GluN2A (also known as Grin2a) and GluN2B (also known as Grin2b) CTDs in two knock-in mice and analyzed the mice's biochemistry, synaptic physiology, and multiple learned and innate behaviors. The eight behaviors were genetically separated into four groups, including one group comprising three types of learning linked to conserved GluN2A/B regions. In contrast, the remaining five behaviors exhibited subunit-specific regulation. GluN2A/B CTD diversification conferred differential binding to cytoplasmic MAGUK proteins and differential forms of long-term potentiation. These data indicate that vertebrate behavior and synaptic signaling acquired increased complexity from the duplication and diversification of ancestral GluN2 genes.

19 July 2019 in Neuropsychopharmacology Reports
Verified
Journal Article
Open access
PDF file
RNRyuichi Nakajima
Ryuichi Nakajima
KTKeizo Takao
Keizo Takao
SHSatoko Hattori
Satoko Hattori
HSHirotaka Shoji
Hirotaka Shoji
NKNoboru Komiyama
Noboru Komiyama
TMTsuyoshi Miyakawa
Tsuyoshi Miyakawa
Aims: Synaptic Ras GTPase‐activating protein 1 (SYNGAP1) regulates synaptic plasticity through AMPA receptor trafficking. SYNGAP1 mutations have been found in human patients with intellectual disability (ID) and autism spectrum disorder (ASD). Almost every individual with SYNGAP1‐related ID develops epilepsy, and approximately 50% have ASD. SYNGAP1‐related ID is estimated to account for at least 1% of ID cases. In mouse models with Syngap1 mutations, strong cognitive and affective dysfunctions have been reported, yet some findings are inconsistent across studies. To further understand the behavioral significance of the SYNGAP1 gene, we assessed various domains of behavior in Syngap1 heterozygous mutant mice using a behavioral test battery.Methods: Male mice with a heterozygous mutation in the Syngap1 gene (Syngap1−/+ mice) created by Seth Grant's group were subjected to a battery of comprehensive behavioral tests, which examined general health, and neurological screens, rotarod, hot plate, open field, light/dark transition, elevated plus maze, social interaction, prepulse inhibition, Porsolt forced swim, tail suspension, gait analysis, T‐maze, Y‐maze, Barnes maze, contextual and cued fear conditioning, and home cage locomotor activity. To control for type I errors due to multiple‐hypothesis testing, P‐values below the false discovery rate calculated by the Benjamini‐Hochberg method were considered as study‐wide statistically significant.Results: Syngap1−/+ mice showed increased locomotor activity, decreased prepulse inhibition, and impaired working and reference spatial memory, consistent with preceding studies. Impairment of context fear memory and increased startle reflex in Syngap1 mutant mice could not be reproduced. Significant decreases in sensitivity to painful stimuli and impaired motor function were observed in Syngap1−/+ mice. Decreased anxiety‐like behavior and depression‐like behavior were noted, although increased locomotor activity is a potential confounding factor of these phenotypes. Increased home cage locomotor activity indicated hyperlocomotor activity not only in specific behavioral test conditions but also in familiar environments.Conclusion: In Syngap1−/+ mice, we could reproduce most of the previously reported cognitive and emotional deficits. The decreased sensitivity to painful stimuli and impaired motor function that we found in Syngap1−/+ mice are consistent with the common characteristics of patients with SYNGAP‐related ID. We further confirmed that the Syngap1 heterozygote mouse recapitulates the symptoms of ID and ASD patients.

21 July 2017 in eLife
Verified
Journal Article
Open access
JMJamie McQueen
Jamie McQueen
TRTomás J Ryan
Tomás J Ryan
SMSean McKay
Sean McKay
KMKatie Marwick
Katie Marwick
PBPaul Baxter
Paul Baxter
GHGiles Hardingham
Giles Hardingham
Aberrant NMDA receptor (NMDAR) activity contributes to several neurological disorders, but direct antagonism is poorly tolerated therapeutically. The GluN2B cytoplasmic C-terminal domain (CTD) represents an alternative therapeutic target since it potentiates excitotoxic signaling. The key GluN2B CTD-centred event in excitotoxicity is proposed to involve its phosphorylation at Ser-1303 by Dapk1, that is blocked by a neuroprotective cell-permeable peptide mimetic of the region. Contrary to this model, we find that excitotoxicity can proceed without increased Ser-1303 phosphorylation, and is unaffected by Dapk1 deficiency in vitro or following ischemia in vivo. Pharmacological analysis of the aforementioned neuroprotective peptide revealed that it acts in a sequence-independent manner as an open-channel NMDAR antagonist at or near the Mg2+ site, due to its high net positive charge. Thus, GluN2B-driven excitotoxic signaling can proceed independently of Dapk1 or altered Ser-1303 phosphorylation.

1 October 2018 in Cell Reports
Verified
Journal Article
Open access
SMSean McKay
Sean McKay
TRTomás J. Ryan
Tomás J. Ryan
JMJamie McQueen
Jamie McQueen
TITim Indersmitten
Tim Indersmitten
KMKatie Marwick
Katie Marwick
NKNoboru Komiyama
Noboru Komiyama
The GluN2 subtype (2A versus 2B) determines biophysical properties and signaling of forebrain NMDA receptors (NMDARs). During development, GluN2A becomes incorporated into previously GluN2B-dominated NMDARs. This "switch" is proposed to be driven by distinct features of GluN2 cytoplasmic C-terminal domains (CTDs), including a unique CaMKII interaction site in GluN2B that drives removal from the synapse. However, these models remain untested in the context of endogenous NMDARs. We show that, although mutating the endogenous GluN2B CaMKII site has secondary effects on GluN2B CTD phosphorylation, the developmental changes in NMDAR composition occur normally and measures of plasticity and synaptogenesis are unaffected. Moreover, the switch proceeds normally in mice that have the GluN2A CTD replaced by that of GluN2B and commences without an observable decline in GluN2B levels but is impaired by GluN2A haploinsufficiency. Thus, GluN2A expression levels, and not GluN2 subtype-specific CTD-driven events, are the overriding factor in the developmental switch in NMDAR composition.

16 October 2019 in European Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
FZFei Zhu
Fei Zhu
MCMark Collins
Mark Collins
JHJohan Harmse
Johan Harmse
JCJyoti S. Choudhary
Jyoti S. Choudhary
SGSeth G.N. Grant
Seth G.N. Grant
NKNoboru Komiyama
Noboru Komiyama
In recent years, the remarkable molecular complexity of synapses has been revealed, with over 1000 proteins identified in the synapse proteome. Although it is known that different receptors and other synaptic proteins are present in different types of neurons, the extent of synapse diversity across the brain is largely unknown. This is mainly due to the limitations of current techniques. Here we report an efficient method for the purification of synaptic protein‐complexes, fusing a high‐affinity tag to endogenous PSD95 in specific cell types. We also developed a strategy which enables the visualization of endogenous PSD95 with fluorescent‐proteins tag in Cre‐recombinase expressing cells. We demonstrate the feasibility of proteomic analysis of synaptic protein‐complexes and visualization of these in specific cell types. We find that the composition of PSD95‐complexes purified from specific cell types differs from those extracted from tissues with diverse cellular composition. The results suggest that there might be differential interactions in the PSD95‐complexes in different brain regions. We have detected differentially interacting proteins by comparing datasets from the whole hippocampus and the CA3 subfield of the hippocampus. Therefore, these novel conditional PSD95 tagging lines will not only serve as powerful tools for precisely dissecting synapse diversity in specific brain regions and subsets of neuronal cells, but also provide an opportunity to better understand brain region‐ and cell type‐specific alterations associated with various psychiatric/neurological diseases. These newly developed conditional gene‐tagging methods can be applied to many different synaptic proteins and will facilitate research on the molecular complexity of synapses.